RET amplifications have been observed in several other tumor types, including hepatobiliary cancers [88,89], prostate cancer [88], breast cancer [77], glioblastoma [90], stomach adenocarcinoma [91], colorectal adenocarcinoma [91], and bladder urothelial carcinoma [91]. This evidence concerns the gene RET and colorectal adenocarcinoma.